Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to explore the mechanism of action of Mucinex, an oral,
over-the-counter, FDA approved expectorant in patients with acute respiratory tract
infections.
Phase:
Phase 2
Details
Lead Sponsor:
Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Guaifenesin Phenylpropanolamine